A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

NCT00540618 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: MEDI-507
OTHER: Placebo
DRUG: MEDI-507
DRUG: MEDI-507

Sponsor

MedImmune LLC